MedTrace Logo

Comparison Study of Insulin Glargine and NPH Insulin

NCT01854723 · Status: WITHDRAWN · Phase: PHASE4 · Type: INTERVENTIONAL

Last updated 2020-03-10

No results posted yet for this study

Summary

This study will compare the safety, effectiveness, and cost of two different types of long-acting insulin.

Conditions

Interventions

DRUG

Switching to NPH insulin

Patients in this arm will be transitioned from insulin glargine to NPH insulin with subsequent titration according to algorithm within protocol. If needed, meal-time insulin will be added during study period.

DRUG

Continuation of insulin glargine

Patients in this group will serve as a control group, and information will be collected regarding the safety, effectiveness, and cost of treatment for use in this study.

Sponsors & Collaborators

  • Providence Health & Services

    lead OTHER

Principal Investigators

  • Elizabeth Stephens, MD · Providence Medical Group

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Max Age
85 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-04-30
Primary Completion
2015-12-31
Completion
2015-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01854723 on ClinicalTrials.gov